Drug Type Small molecule drug |
Synonyms Compound 33 |
Target |
Mechanism HSPA9 modulators(heat shock protein family A (Hsp70) member 9 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H38N4OS |
InChIKeyMCYZOKRREHHHFL-UHFFFAOYSA-N |
CAS Registry2922680-16-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Endometrial Carcinoma | Preclinical | CN | 31 Jul 2024 |